Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States

NCT04928599 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT04928599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04928599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Active, not recruiting
Start date
March 14, 2022
Completion date
March 31, 2028
Enrollment
100 (estimated)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia